The import of antisera and other blood fractions to the UK is forecasted to grow steadily from $10.443 billion in 2024 to $11.829 billion in 2028, marking a Compound Annual Growth Rate (CAGR) of approximately 3.1%. Comparing year-on-year growth rates, we see consistent increases of around 3.4% annually from 2025 to 2028. As we entered 2024, the actual import value in 2023 was just under $10 billion, highlighting the gradual growth trajectory anticipated over the next five years.
Future trends to watch for include:
- The impact of global health developments on demand for these medical products.
- Potential regulatory changes in the UK and across key supplier nations.
- Technological advancements in biosimilars and their effect on the market.
